Inhibikase Therapeutics, Inc. short interest in 2023
In 2023, Inhibikase Therapeutics, Inc.'s disclosed short interest ran from 0.43% of shares outstanding on 13 Jan 2023 to 2.25% on 15 Nov 2023, a change of +1.82 percentage points. The year's high was 2.25% on 15 Nov 2023 and its low 0.43% on 13 Jan 2023, averaging 0.98% across 13 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.74 days on 31 May 2023. Full history: Inhibikase Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 0.43% (13 Jan 2023)
- End of year
- 2.25% (15 Nov 2023)
- Change
- +1.82 pp
- High
- 2.25% (15 Nov 2023)
- Low
- 0.43% (13 Jan 2023)
- Average
- 0.98%
- Highest days to cover
- 3.74 (31 May 2023)
- SEC filings marked
- 4
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 0.43% | 3.55 | |
| 15 Mar 2023 | 1.55% | 1.00 | |
| 31 Mar 2023 | 1.75% | 1.00 | 10-K filed |
| 14 Apr 2023 | 0.91% | 1.56 | |
| 28 Apr 2023 | 1.07% | 1.26 | |
| 15 May 2023 | 1.20% | 3.55 | 10-Q filed |
| 31 May 2023 | 0.75% | 3.74 | |
| 15 Jun 2023 | 0.51% | 2.66 | |
| 15 Aug 2023 | 0.57% | 2.02 | 10-Q filed |
| 31 Aug 2023 | 0.43% | 1.00 | |
| 15 Sep 2023 | 0.43% | 1.00 | |
| 29 Sep 2023 | 0.89% | 1.00 | |
| 15 Nov 2023 | 2.25% | 2.71 | 10-Q filed |
See also: Inhibikase Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.